Cargando…
Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients
Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized by cognitive decline. Prodromal stage of AD, also called mild cognitive impairment (MCI), especially its amnestic type (aMCI), precedes dementia stage of AD. There are currently no reliable diagnostic biomarkers of AD...
Autores principales: | Chmátalová, Zuzana, Vyhnálek, Martin, Laczó, Jan, Hort, Jakub, Skoumalová, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929292/ https://www.ncbi.nlm.nih.gov/pubmed/26991927 http://dx.doi.org/10.1111/jcmm.12824 |
Ejemplares similares
-
Blood markers of oxidative stress in Alzheimer's disease
por: Skoumalová, Alice, et al.
Publicado: (2012) -
Emotional prosody recognition is impaired in Alzheimer’s disease
por: Amlerova, Jana, et al.
Publicado: (2022) -
Different Profiles of Spatial Navigation Deficits In Alzheimer’s Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2022) -
Spatial Pattern Separation Testing Differentiates Alzheimer’s Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2021) -
Famous Landmark Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
por: Sheardova, Katerina, et al.
Publicado: (2014)